null
SMILES: CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(ncc3C2=O)N(C)C)cc1)c1cccs1
InChI Key: InChIKey=CMVIUAMERNJGJV-QHCPKHFHSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436608 ((S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methyla...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436608 ((S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methyla...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent noradrenaline transporter (Homo sapiens (Human)) | BDBM436608 ((S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methyla...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair |